Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Palifosfamide is an active metabolite of the DNA alkylating agent ifosfamide (Item No. 17562).1 Palifosfamide is formed through hydroxylation of ifosfamide by various hepatic cytochrome P450 (CYP) isoforms.2 It is cytotoxic to L1210 and CCRF-CEM cancer cells when used at a concentration of 100 µM.3 Palifosfamide (100 mg/kg per day) reduces tumor growth in murine Lewis lung carcinoma and L1210 leukemia models, as well as a rat Yoshida ascitic sarcoma model.1
WARNING This product is not for human or veterinary use.
1. Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide. Br. J. Cancer 47(1), 15-26 (1983).
2. PharmGKB summary: ifosfamide pathways, pharmacokinetics and pharmacodynamics. Pharmacogenet. Genom. 24(2), 133-138 (2014).
3. Preclinical pharmacokinetics and stability of isophosphoramide mustard. Cancer Chemother. Pharmacol. 33(5), 391-398 (1994).